FCVGR 2021 consist of weekly CME sessions on a variety of dermatological diseases and tools.

Please join us for this week's session:
Wednesday, February 10, 2021
8 PM EST/ 5 PM PST

Your Burning Questions from WC21: Information That Can Make an Impact - Part 1

Featured Topics: Acne, Actinic Keratoses, COVID-19, and Genomics

Log in to Begin Activity

Hilary Baldwin, MD

Faculty

Clinical Associate Professor Dermatology
Rutgers Robert Wood Johnson Medical Center
New Brunswick, NJ

Neal Bhatia, MD

Faculty

Director of Clinical Dermatology
Therapeutics Clinical Research
San Diego, California

Laura Ferris, MD, PhD

Faculty

Associate Professor of Dermatology
University of Pittsburgh
Pittsburgh, PA

Mark Lebwohl, MD

Moderator

Dean for Clinical Therapeutics
Waldman Professor and Chairman
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

Upon completion of this activity, the participant should be better able to:

Apply new knowledge and clinical pearls that can be immediately incorporated in clinical settings
Integrate new treatment options and techniques for treating patients with a variety of dermatologic conditions
Discuss the latest clinical data to evaluate the optimal use of therapies for your patients

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and Dermatology University. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONFLICTS OF INTEREST/DISCLOSURES

Hilary E. Baldwin, MD
Consultant and Speaker's Bureau: Almirall, Bausch, Galderma, SolGel, Sun, and Vyne.

Neal D. Bhatia, MD
Grant/Research Support: Almirall, Biofrontera, BMS, EPI Health, Ferndale, Galderma, Incyte, ISDIN, L&J, LaRoche Posay,LEO, Mayne, Ortho Dermatologics, Pfizer, Sanofi Genzyme Regeneron, SUN, Vyne
Consultant: Almirall, Biofrontera, BMS, Dermira, EPI Health, Ferndale, Galderma, Incyte, ISDIN, J&J, LaRoche Posay, LEO, Mayne, Ortho Dermatologics, Sanofi Genzyme Regeneron, SUN, Vyne

Laura K. Ferrris, MD
Grant/Research Support: Castle Biosciences
Consultant: DermTech, Scibase

Mark Lebwohl, MD
Grant/Research Support: Abbvie, Amgen, Arcutis, Boehringer-Ingelheim, Dermavant, Lilly, Incyte, Janssen, Leo, Ortho Dermatologics, Pfizer, UCB
Consultant: Aditum Bio, Allergan, Almirall, Arcutis, Avotres Therapeutics, BirchBioMed, BMD Skincare, Boehringer-Ingelheim, BMS, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant, EMD Serono, Evelo Biosciences, Facilitation of International Dermatology Education, Foundation for Research and Education in Dermatology, Helsinn Therapeutics, Inozyme Pharma, Kyowa Kirin, Leo, Meiji Seika Pharma, Menlo, Neuroderm, Pfizer, Promius/ Dr. Reddy’s Labs, Theravance, Verrica

Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.

2021 Virtual Grand Rounds Session 1

Hilary Baldwin, MD

Neal Bhatia, MD

Laura Ferris, MD, PhD

Mark Lebwohl, MD

CONFLICTS OF INTEREST/DISCLOSURES

2021 Virtual Grand Rounds
Session 1